NCT00666536View on ClinicalTrials.gov

The Effects of Moderate vs. Aggressive Treatment With Valsartan + Amlodipine on Patients With Hypertension Uncontrolled by Angiotensin-Receptor Blocker (Herein, ARB) Monotherapy

PHASE4CompletedINTERVENTIONAL
Enrollment

728

Participants

Timeline

Start Date

March 31, 2008

Primary Completion Date

January 31, 2009

Conditions
Hypertension
Interventions
DRUG

valsartan and amlodipine

DRUG

valsartan and amlodipine

Trial Locations (1)

70002

Egan Healthcare, Metairie

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY

NCT00666536 - The Effects of Moderate vs. Aggressive Treatment With Valsartan + Amlodipine on Patients With Hypertension Uncontrolled by Angiotensin-Receptor Blocker (Herein, ARB) Monotherapy | Biotech Hunter | Biotech Hunter